Mizuho analyst Vikram Malhotra raised the firm’s price target on Omega Healthcare (OHI) to $40 from $37 and keeps a Neutral rating on the shares. The firm believes the shares of senior housing real estate investment trusts are pricing in a lot of goof news.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $44 from $39 at Truist
- Omega Healthcare price target raised to $46 from $42 at Raymond James
- Omega Healthcare price target raised to $42 from $39 at Scotiabank
- MedaSync announces strategic investment from Omega Healthcare
- Omega Healthcare Investors Reports Strong Q2 2025 Results